Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Time-dose relationships in radiation-enhanced integration.

C W Stevens1, M Puppi, G J Cerniglia

  • 1Department of Radiation Oncology, University of Texas M.D. Anderson Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. cstevens@mdanderson.org

International Journal of Radiation Biology
|September 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Positioning of Melflufen in Heavily Pretreated RRMM Patients: Real-World Evidence in a Rapidly Evolving Therapeutic Landscape.

European journal of haematology·2026
Same author

A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide.

Clinical and experimental medicine·2025
Same author

Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?

Journal of cancer research and clinical oncology·2025
Same author

Bispecific Antibodies and CAR T in Multiple Myeloma: Appropriate Selection of Patients and Sequencing.

Mediterranean journal of hematology and infectious diseases·2025
Same author

Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma.

Journal of bone oncology·2025
Same author

Clinical Presentation and Long-Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study.

Cancer medicine·2024

Ionizing radiation induces a long-lasting hyper-recombination state in cells, enhancing gene delivery. This effect, lasting days after irradiation, is crucial for optimizing radiation-gene therapy approaches.

Area of Science:

  • Molecular Biology
  • Radiation Oncology
  • Gene Therapy

Background:

  • Ionizing radiation is known to increase genetic recombination.
  • Stable transduction of plasmid and adenoviral vectors is enhanced by radiation.
  • Understanding the duration of this radiation-induced recombination is critical for gene therapy applications.

Purpose of the Study:

  • To determine the duration of increased recombination following ionizing radiation exposure.
  • To investigate the dose and fractionation dependence of radiation-induced recombination.

Main Methods:

  • A549 and NIH/3T3 cells were irradiated using various fractionation schemes.
  • Cells were transfected at different time points post-irradiation.
  • Enhanced integration (EI) levels were quantified.

Related Experiment Videos

Main Results:

  • Enhanced integration (EI) persists for at least 2-3 days after single radiation fractions.
  • The duration of EI activation is dependent on the radiation dose.
  • EI efficiency is dose-dependent but independent of fractionation when corrected for cytotoxicity.

Conclusions:

  • Radiation induces a long-lived hyper-recombination state relevant to clinical radiotherapy.
  • This finding is timely for improving gene delivery in radiation-gene therapy trials.
  • Understanding recombination events can optimize cancer treatment strategies.